首页> 外国专利> FUNCTIONAL PLG COPOLYMERS, THEIR NANOPARTICLES, THEIR PRODUCTION AND APPLICATION FOR ADDRESSED DELIVERY OF THE MEDICINE AND OBTAINING THE IMAGE

FUNCTIONAL PLG COPOLYMERS, THEIR NANOPARTICLES, THEIR PRODUCTION AND APPLICATION FOR ADDRESSED DELIVERY OF THE MEDICINE AND OBTAINING THE IMAGE

机译:功能性PLG共聚物,它们的纳米颗粒,它们的生产和用于药物的直接递送和获取图像的应用

摘要

1. The compound of formula (A), where: PLA is a polylactide residue; PEG is a polyethylene glycolide residue; linker PEG 'is a polyethylene glycolide residue; The ligand is the remainder of the functional ligand. 2. The compound of formula (A) according to claim 1, where PEG 'has the formula, where: n' is the number of units and is equal to from 1 to 10, (1) is the addition of a bond to the - (CH) -triazole group; (2) is the addition bonds to the ligand. 3. The compound of formula (A) according to claim 1 or 2, wherein the PL has the formula: wherein: (3) is a bond attachment to a PEG group; and m is the number of units and is equal to from 1 to 500.4. The compound of formula (A) according to claim 1 or 2, where the PEG has the formula: where: (4) is the attachment of a bond to -PL; (5) is the attachment of a bond to a nitrogen atom and n is the number of units and is equal to from 1 and 300.5. The compound of formula (A) according to claim 1 or 2, wherein the ligand is selected from the residues of the guidance device, diagnostic agents, imaging agents, stimulus-sensitive agents, coupling agents, cell penetration enhancing agents, antitoxic components and drugs. . The compound of formula (A) according to claim 5, wherein said pointing device is a ligand-recognizing membrane. The compound of formula (A) according to claim 1 or 2, wherein the ligand is selected from: ligands that recognize membranes selected from an estrogen receptor antagonist, an androgen receptor antagonist, folic acid, anisamide, an antibody capable of recognizing the corresponding surface antigen, an RGD sequence that binds with αβ integrins overly expressed on the angiogenic endothelium of the tumor, hyaluronic acid, transferrin, peptide-directed gene vectors, aptamers or tumor necrosis factor, diagnostic / receiving agents and
机译:1.式(A)的化合物,其中:PLA是聚丙交酯残基; PEG是聚乙交酯残基;接头PEG'是聚乙交酯残基;配体是功能性配体的其余部分。 2.根据权利要求1所述的式(A)的化合物,其中,PEG'具有下式:其中:n'是单元数并且等于1至10,(1)是在其上加成一个键。 -(CH)-三唑基; (2)是与配体的加成键。 3.根据权利要求1或2所述的式(A)的化合物,其中所述PL具有下式:其中:(3)是与PEG基团的键连接;以及m是单位数,从1到500.4。 3.根据权利要求1或2所述的式(A)的化合物,其中,所述PEG具有下式:其中:(4)是键与-PL的连接; (5)是键与氮原子的连接,n是单元数,等于1至300.5。 3.根据权利要求1或2所述的式(A)的化合物,其中所述配体选自所述引导装置的残基,诊断剂,显像剂,刺激敏感剂,偶联剂,细胞渗透增强剂,抗毒成分和药物。 。 。 6.根据权利要求5的式(A)化合物,其中所述指示装置是配体识别膜。 3.根据权利要求1或2所述的式(A)的化合物,其中,所述配体选自:识别选自雌激素受体拮抗剂,雄激素受体拮抗剂,叶酸,茴香胺,能够识别对应表面的抗体的膜的配体。抗原,RGD序列与在肿瘤的血管生成内皮细胞中过度表达的αβ整联蛋白结合,透明质酸,转铁蛋白,肽导向的基因载体,适体或肿瘤坏死因子,诊断/接受剂和

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号